A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age
Clinical trial NCT07117487 · COMPLETED
Trial details
- NCT number
- NCT07117487
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2026-03-27
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.